Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data

Ekin Kırcalı Guldane Cengiz Seval Cemaleddin Öztürk Hülya YılmazDerya KoyunSinem Civriz Bozdag Selami Kocak Toprak Pervin Topçuoğlu Önder Arslan Muhit Özcan Taner Demirer Osman Ilhan Gunhan Gurman Meral Beksac Meltem Kurt Yüksel

Published in: Balkan medical journal (2022)

The results confirmed that eltrombopag could provide a rapid, sustained response in patients with poor graft functioning after haematopoietic cell transplantation. This finding is essential given the high rate of non-relapse mortality caused by poor graft functioning after haematopoietic cell transplantation.

Keyphrases

cell therapy
single cell
stem cells
type diabetes
cardiovascular disease
mesenchymal stem cells